Form EFFECT Cellectis S.A.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | July 11, 2025 4:00 P.M. |
| Form: | F-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cellectis receives FDA RMAT designation for blood cancer therapy
- GraniteShares Launches SPAL and SNK, Offering 2x Leveraged and Inverse Access to SpaceX
- Chablis Capital Corp. and Viridian Metals Ireland Limited Close $3 Million of Its Subscription Receipts Financing in Connection with Proposed Qualifying Transaction
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
